Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI episode artwork

EPISODE · Mar 30, 2026

Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI

from Vitals & Signals

The FDA is quietly rewriting the fundamental contract of clinical AI regulation — moving from a pre-market permission slip to a post-market surveillance regime — and every founder, investor, and clinician in this industry needs to understand what that means before the framework lands.

NOW PLAYING

Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Vitals & Signals?

Episode duration information is not available.

When was this Vitals & Signals episode published?

This episode was published on March 30, 2026.

What is this episode about?

The FDA is quietly rewriting the fundamental contract of clinical AI regulation — moving from a pre-market permission slip to a post-market surveillance regime — and every founder, investor, and clinician in this industry needs to understand what...

Can I download this Vitals & Signals episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!